Precipio (NASDAQ:PRPO – Get Free Report) and Mitesco (OTCMKTS:MITI – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, institutional ownership, earnings, valuation, dividends and analyst recommendations.
Volatility and Risk
Precipio has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500. Comparatively, Mitesco has a beta of 4.88, suggesting that its stock price is 388% more volatile than the S&P 500.
Valuation & Earnings
This table compares Precipio and Mitesco”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Precipio | $24.05 million | 1.67 | -$360,000.00 | ($0.47) | -47.77 |
| Mitesco | $40,000.00 | 32.51 | $500,000.00 | ($0.33) | -0.19 |
Mitesco has lower revenue, but higher earnings than Precipio. Precipio is trading at a lower price-to-earnings ratio than Mitesco, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Precipio and Mitesco’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Precipio | -3.57% | -6.73% | -4.49% |
| Mitesco | -7,638.20% | -2.18% | -2,982.65% |
Analyst Ratings
This is a breakdown of recent ratings and target prices for Precipio and Mitesco, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Precipio | 1 | 0 | 0 | 0 | 1.00 |
| Mitesco | 0 | 0 | 0 | 0 | 0.00 |
Institutional and Insider Ownership
10.5% of Precipio shares are owned by institutional investors. Comparatively, 0.0% of Mitesco shares are owned by institutional investors. 16.6% of Precipio shares are owned by company insiders. Comparatively, 4.9% of Mitesco shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
About Precipio
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.
About Mitesco
Mitesco, Inc. does not have significant operations. Previously, it was engaged in healthcare technology and services business. Mitesco, Inc. is based in Vero Beach, Florida.
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.
